Regeneron Pharmaceuticals, Inc.REGNNASDAQ
Loading
Operating Income ContractionContracting
Percentile Rank71
3Y CAGR-12.7%
5Y CAGR+0.0%
Year-over-Year Change
Profit from core business operations before interest and taxes
3Y CAGR
-12.7%/yr
vs +20.7%/yr prior
5Y CAGR
+0.0%/yr
Recent deceleration
Acceleration
-33.5pp
Decelerating
Percentile
P71
Within normal range
vs 5Y Ago
1x
Modest growth
Streak
4 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $3.58B | -10.3% |
| 2024 | $3.99B | -8.2% |
| 2023 | $4.35B | -19.3% |
| 2022 | $5.39B | -39.8% |
| 2021 | $8.95B | +150.1% |
| 2020 | $3.58B | +61.9% |
| 2019 | $2.21B | -12.8% |
| 2018 | $2.53B | +21.9% |
| 2017 | $2.08B | +56.3% |
| 2016 | $1.33B | - |